Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director · Executive Chairman · 10% owner | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 100,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 100,000 · Balance 100,000 F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, then 1/48 of the options vesting each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 48,000 | $13.04 | $625,920.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 9 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,126,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 15,000 | $51.81 | $777,102.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 8 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 15,000 | $15.34 | $230,100.00 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 7 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 18,461 | $51.81 | $956,405.33 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 6 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 18,461 | $10.66 | $196,794.26 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 5 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 18,461 | $51.81 | $956,405.33 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 4 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 18,461 | $11.86 | $218,993.61 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 3 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 18,461 | $51.81 | $956,405.33 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 2 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078,000 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.155, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 26, 2018 Filed May 1, 2018 00:59 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 18,461 | $4.88 | $90,089.68 |
DisclosureSEC source: 0001209191-18-026950 · doc4.xml · nonDerivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,096,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:11 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-18-005088 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Executive Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2028-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:02 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 150,000 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-17-006645 · doc4.xml · derivative · entry 1 Paul David C · CIK 0001555391 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Class A Common Stock · 150,000 shares Expires 2027-01-30 F1 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.